Scores here are heuristic signals about sourcing and corroboration across outlets — not verdicts on whether a story is true, and not an endorsement or condemnation of any outlet. How this works
Caribou Biosciences is shutting down after failing to raise the money necessary to fund a late-stage clinical trial of its off-the-shelf CAR-T therapy for lymphoma.
1
independent outlets · 100% owner-diverse
Save this story
Connect "Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down - STAT" to your own research notes and market positions — Next Level Intelligence links what you save to the assets and notes it actually affects.